NanoString Technologies, Inc. (NSTG)
After hours:
| Previous close | 10.39 |
| Open | 10.26 |
| Bid | 10.28 x 800 |
| Ask | 11.00 x 900 |
| Day's range | 10.10 - 10.85 |
| 52-week range | 4.37 - 41.00 |
| Volume | |
| Avg. volume | 1,027,077 |
| Market cap | 502.852M |
| Beta (5Y monthly) | 1.54 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.78 |
| Earnings date | 27 Feb 2023 - 03 Mar 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 17.00 |
- Business Wire
NanoString Releases Single Cell Spatial Transcriptomics Dataset Highlighting Data Quality of CosMx Spatial Molecular Imager
SEATTLE, January 19, 2023--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a public release of new data generated by the CosMx™ Spatial Molecular Imager (SMI). This data was generated from formalin-fixed paraffin-embedded (FFPE) human liver samples and showcases the best-in-class data quality of the CosMx SMI. The dataset highlights CosMx SMI’s high sensitivity, with the capability to detect and quan
- Business Wire
NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2022
SEATTLE, January 08, 2023--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational highlights for the fourth quarter and fiscal year ended December 31, 2022.
- Business Wire
National Geographic Highlights Use of the CosMx Spatial Molecular Imager in Alzheimer’s Disease Research
SEATTLE, January 03, 2023--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s CosMx™ Spatial Molecular Imager (SMI) has been highlighted in the January edition of National Geographic Magazine. An article entitled ‘Living Longer and Better’ highlighted research from Wake Forest University, which used the CosMx SMI to study human brain tissue from patients with Alzheimer’s disease to re
